Palacio-Portilla, E JRoquer, JAmaro, SArenillas, J FAyo-Martín, OCastellanos, MFreijo, M MFuentes, BGarcía-Pastor, AGomis, MGómez-Choco, MLópez-Cancio, EMartínez-Sánchez, PMorales, ARodríguez-Yáñez, MSegura, TSerena, JVivancos-Mora, Jde Leciñana, M AComité ad hoc del Grupo de Estudio de Enfermedades Cerebrovasculares de la Sociedad Española de Neurología2023-05-032023-05-032020-11-04http://hdl.handle.net/10668/22444We present an update of the Spanish Society of Neurology's recommendations for prevention of both primary and secondary stroke in patients with dyslipidaemia. We performed a systematic review to evaluate the main aspects of the management of dyslipidaemias in primary and secondary stroke prevention and establish a series of recommendations. In primary prevention, the patient's vascular risk should be determined in order to define target values for low-density lipoprotein cholesterol. In secondary prevention after an atherothrombotic stroke, a target valueenDislipidemiaDyslipidaemiaEstatinasIctusLDL cholesterolLDL colesterolPrevenciónPreventionStatinsStrokeresearch article3316072210.1016/j.nrl.2020.07.0272173-5808